Novel antibacterial agent against multidrug-resistant Escherichia coli at low concentrations as 0.007 mM, disintegrating membrane, accelerating ROS accumulation, reducing bacterial metabolism, and intercalating into DNA groove

Novel antibacterial agent against multidrug-resistant Escherichia coli at low concentrations as 0.007 mM, disintegrating membrane, accelerating ROS accumulation, reducing bacterial metabolism, and intercalating into DNA groove

Long-acting calcium-blocking agent with significant anti-anginal activity

Useful pharmaceutical building block

Anorectic, primarily promoting weight loss through reduced appetite

Inhibitor of 4-hydroxyphenylpyruvate dioxygenase (HPPD), acting as a herbicide

anti-HSV agent

Potent D2/D4 dopamine receptor antagonist, neuroleptic and antipsychotic

Antiandrogen, being effective in the treatment of acne, seborrhea, and hirsutism in women

Irreversible and nonselective Monoamine_oxidase_inhibitor>monoamine oxidase inhibitor (MAOI)

Novel inhibitor of HIV-1 Rev function, also acting as a cytostatic agent with substantial antiretroviral activity

Novel potent PI3K inhibitor, suppressing metastasis of non-small cell lung cancer cells by modulating β-catenin/ZEB1 regulatory loop, blocking AKT phosphorylation

Inhibitor of angiotensin-converting enzyme (ACE); Prodrug of benazeprilat

Inhibitor of monoamine oxidase; Anti-serotonin agent

Novel potent and specific inhibitor of dog gastric lipase (DGL)

Fatty Ester for Lipid Research

Active metabolite of beclomethasone dipropionate

Novel CBP/p300 Bromodomains inhibitor, binding BRD4 almost identical to SGC-CBP30

Novel specific bona fide EthR-inhibitor, boosting ETH 4 times in an intravenously infected TB mice model

Novel EthR inhibitor and ethionamide booster

Novel activator of ethionamide

Novel EthR inhibitor, boosting antituberculous activity of ethionamide

Potent and selective hydroxamate PfAM1 inhibitor

Sodium channel enhancer

Novel small molecule PTP1B inhibitor

Potent and selective

Novel Bcr-Abl inhibitor, potently inhibited Bcr-AblWT and Bcr-AblT315I kinases with IC 50 of 0.043 μM and 0.17 μM, respectively

Novel highly potent inhibitor of breakpoint cluster region-abelson kinase (Bcr-Abl) including the T315I mutant

Clearing cycloalkyne for click reaction with Azido-Warfarin WN3 or other Azido-containing drugs

Novel Cell-Permeable Probe for the Identification of Protein Sulfenic Acids